journal article·2024-08Open access

E3 Ubiquitin Ligase RNF13 Suppresses TLR Lysosomal Degradation by Promoting LAMP‐1 Proteasomal Degradation

Wei Liu, Yuyang Wang, Shuo Liu, Xuan Zhang, Xuetao Cao, Minghong Jiang

Advanced Science· Volume 11· Issue 32

Abstract

Abstract As a highly organized system, endo‐lysosomes play a crucial role in maintaining immune homeostasis. However, the mechanisms involved in regulating endo‐lysosome progression and subsequent inflammatory responses are not fully understood. By screening 103 E3 ubiquitin ligases in regulating endo‐lysosomal acidification, it is discovered that lysosomal RNF13 inhibits lysosome maturation and promotes inflammatory responses mediated by endosomal Toll‐like receptors (TLRs) in macrophages. Mechanistically, RNF13 mediates K48‐linked polyubiquitination of LAMP‐1 at residue K128 for proteasomal degradation. Upon TLRs activation, LAMP‐1 promotes lysosomes maturation, which accelerates lysosomal degradation of TLRs and reduces TLR signaling in macrophages. Furthermore, peripheral blood mononuclear cells (PBMCs) from patients with rheumatoid arthritis (RA) show increased RNF13 levels and decreased LAMP‐1 expression. Accordingly, the immunosuppressive agent hydroxychloroquine (HCQ) can increase the polyubiquitination of RNF13. Taken together, the study establishes a linkage between proteasomal and lysosomal degradation mechanisms for the induction of appropriate innate immune response, and offers a promising approach for the treatment of inflammatory diseases by targeting intracellular TLRs.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Autoimmune and Inflammatory Disorders Research · Immune Cell Function and Interaction · Inflammasome and immune disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Immunology Center for Immunotherapy Institute of Basic Medical Sciences Peking Union Medical College Chinese Academy of Medical Sciences Beijing 100005 China

Department of Rheumatology Beijing Hospital National Center of Gerontology Institute of Geriatric Medicine Chinese Academy of Medical Sciences Beijing 100730 China

Funding

National Natural Science Foundation of China · Postdoctoral Research Foundation of China

References (41)

Show source-provided references
1. 10.1016/j.cell.2020.02.04110.1016/j.cell.2020.02.041 ↗
2. 10.1038/s41577-019-0151-610.1038/s41577-019-0151-6 ↗
3. 10.1155/2010/67239510.1155/2010/672395 ↗
4. 10.1038/cmi.2018.410.1038/cmi.2018.4 ↗
5. 10.1038/s41584-020-00544-410.1038/s41584-020-00544-4 ↗
6. 10.1016/j.str.2011.02.00410.1016/j.str.2011.02.004 ↗
7. 10.1007/s00018-020-03656-y10.1007/s00018-020-03656-y ↗
8. 10.1074/jbc.M115.67106510.1074/jbc.M115.671065 ↗
9. 10.1084/jem.2014146110.1084/jem.20141461 ↗
10. 10.1016/j.immuni.2016.07.01010.1016/j.immuni.2016.07.010 ↗
11. 10.1182/blood-2007-01-06602710.1182/blood-2007-01-066027 ↗
12. 10.4049/jimmunol.090024910.4049/jimmunol.0900249 ↗
13. 10.1146/annurev-biochem-061516-04490810.1146/annurev-biochem-061516-044908 ↗
14. 10.1242/jcs.26010110.1242/jcs.260101 ↗
15. 10.1146/annurev-biochem-060815-01492210.1146/annurev-biochem-060815-014922 ↗
16. 10.1152/physiolgenomics.00031.201610.1152/physiolgenomics.00031.2016 ↗
17. 10.1042/BJ2013106710.1042/BJ20131067 ↗
18. 10.1016/j.tcb.2020.11.01110.1016/j.tcb.2020.11.011 ↗
19. 10.3389/fphar.2022.92879410.3389/fphar.2022.928794 ↗
20. 10.1016/j.ajhg.2018.11.01810.1016/j.ajhg.2018.11.018 ↗
21. 10.1111/j.1742-4658.2009.07498.x10.1111/j.1742-4658.2009.07498.x ↗
22. 10.1111/j.1742-4658.2009.06913.x10.1111/j.1742-4658.2009.06913.x ↗
23. 10.1007/s00018-012-1103-510.1007/s00018-012-1103-5 ↗
24. 10.1016/S1074-7613(00)80254-X10.1016/S1074-7613(00)80254-X ↗
25. 10.1074/jbc.274.18.1269210.1074/jbc.274.18.12692 ↗
26. 10.1038/s41590-021-01001-410.1038/s41590-021-01001-4 ↗
27. 10.1056/NEJMra100496510.1056/NEJMra1004965 ↗
28. 10.1016/j.immuni.2009.09.01310.1016/j.immuni.2009.09.013 ↗
29. 10.1016/B978-0-12-397925-4.00009-210.1016/B978-0-12-397925-4.00009-2 ↗
30. 10.1016/j.mam.2006.08.00510.1016/j.mam.2006.08.005 ↗
31. 10.1038/3502259510.1038/35022595 ↗
32. 10.4049/jimmunol.180.1.47510.4049/jimmunol.180.1.475 ↗
33. 10.1016/j.celrep.2022.11134910.1016/j.celrep.2022.111349 ↗
34. 10.3390/cells1011306310.3390/cells10113063 ↗
35. 10.1016/j.csbj.2022.08.01610.1016/j.csbj.2022.08.016 ↗
36. 10.1016/0092-8674(92)90306-W10.1016/0092-8674(92)90306-W ↗
37. 10.1002/j.1460-2075.1994.tb06381.x10.1002/j.1460-2075.1994.tb06381.x ↗
38. 10.1111/imr.1306510.1111/imr.13065 ↗
39. 10.1016/j.jaut.2019.10238210.1016/j.jaut.2019.102382 ↗
40. 10.15252/emmm.20201247610.15252/emmm.202012476 ↗
41. Kay J. · Rheumatology · 2012 · 5110.1093/rheumatology/ker193 ↗